INTRACELLULAR TRIACYLGLYCEROL LIPASE - ITS ROLE IN THE ASSEMBLY OF HEPATIC VERY-LOW-DENSITY LIPOPROTEIN (VLDL)

被引:62
|
作者
GIBBONS, GF
WIGGINS, D
机构
[1] Metabolic Research Laboratory, University of Oxford, Radcliffe Infirmary, Oxford, OX2 6HE, Woodstock Road
来源
ADVANCES IN ENZYME REGULATION, VOL 35 | 1995年 / 35卷
基金
英国医学研究理事会;
关键词
D O I
10.1016/0065-2571(94)00006-O
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular fatty acids entering the hepatocyte are either esterified to cytosolic TAG or oxidized to ketone bodies. Very little is esterified and secreted directly in association with VLDL. Thus, even when extracellular fatty acids are available, the major, direct source of VLDL TAG is the cytosolic pool. The recruitment of cytosolic TAG for VLDL assembly involves lipolysis followed by re-esterification. At least 70% of the secreted TAG is derived via this route. Fatty acids released at this lipolytic step are utilized exclusively for VLDL TAG synthesis and are not available for ketogenesis. Substantially more cytosolic TAG undergoes lipolysis than is required to meet the needs of VLDL assembly. The remaining fatty acids are re-esterified and re-cycled to the cell cytosol. From a physiological viewpoint, the presence of this indirect route for VLDL TAG recruitment would provide a means of regulation of VLDL secretion which is independent of the plasma fatty acid concentration. In this respect, several pathophysiological conditions are known in which there is a negative association between plasma fatty acid concentration and the rate of VLDL secretion. These are: (a) insulin-dependent diabetes, (b) starvation, (c) fat-feeding. Lipolysis of cytosolic TAG and transfer of fatty acids into the ER lumen may provide a regulatory focus for the control of hepatic VLDL output. © 1995.
引用
收藏
页码:179 / 198
页数:20
相关论文
共 50 条
  • [31] Role of Very-Low-Density Lipoprotein Receptor in Lipid Metabolism in Heart
    Hajri, Tahar
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E249 - E249
  • [32] VERY-LOW-DENSITY LIPOPROTEIN IN SEARCH OF PRECISION
    VAISRUB, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (06): : 546 - 546
  • [33] LIPOPROTEIN-LIPASE FACILITATES VERY-LOW-DENSITY LIPOPROTEIN BINDING TO THE SUBENDOTHELIAL CELL-MATRIX
    SAXENA, U
    FERGUSON, E
    AUERBACH, BJ
    BISGAIER, CL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) : 769 - 774
  • [34] VERY-LOW-DENSITY LIPOPROTEIN (VLDL) INDUCES ENORMOUS NITRIC-OXIDE (NO) PRODUCTION IN RAT MACROPHAGES
    MOHAN, PF
    SALAHUDEEN, AK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 586 - 586
  • [35] SEQUENTIAL ASSEMBLY OF HEPATIC VERY LOW-DENSITY LIPOPROTEIN
    JANERO, DR
    LANE, MD
    FEDERATION PROCEEDINGS, 1983, 42 (07) : 1819 - 1819
  • [36] GENETIC ASSOCIATION OF THE VERY-LOW-DENSITY LIPOPROTEIN (VLDL) RECEPTOR GENE WITH SPORADIC ALZHEIMERS-DISEASE
    OKUIZUMI, K
    ONODERA, O
    NAMBA, Y
    IKEDA, K
    YAMAMOTO, T
    SEKI, K
    UEKI, A
    NANKO, S
    TANAKA, H
    TAKAHASHI, H
    OYANAGI, K
    MIZUSAWA, H
    KANAZAWA, I
    TSUJI, S
    NATURE GENETICS, 1995, 11 (02) : 207 - 209
  • [37] EFFECTS OF HORMONES AND PYRUVATE ON THE RATES OF SECRETION OF VERY-LOW-DENSITY LIPOPROTEIN TRIACYLGLYCEROL AND CHOLESTEROL BY RAT HEPATOCYTES
    PULLINGER, CR
    GIBBONS, GF
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 833 (01) : 44 - 51
  • [38] Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
    Choi, Sung Hee
    Ginsberg, Henry N.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2011, 22 (09): : 353 - 363
  • [39] Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients
    Nielsen, SU
    Bassendine, MF
    Burt, AD
    Martin, C
    Pumeechockchai, W
    Toms, GL
    JOURNAL OF VIROLOGY, 2006, 80 (05) : 2418 - 2428
  • [40] Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL:: An alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta, V
    Autran, D
    Ponsin, G
    Marcais, C
    Duvillard, L
    Verges, B
    Berthezene, F
    Moulin, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02): : 797 - 803